Phase I Study of SB-480848(Darapladib) -Repeat Dose Study in Healthy Japanese Male Subjects-
Status:
Completed
Trial end date:
2008-03-01
Target enrollment:
Participant gender:
Summary
This study is being conducted to provide safety, tolerability, PK and PD data in repeat
dosing that will allow further studies with darapladib in Japanese patients